Physicochemical Properties
| Molecular Formula | C24H20CLN3O |
| Molecular Weight | 401.894 |
| Exact Mass | 401.129 |
| CAS # | 174262-13-6 |
| Related CAS # | 174262-13-6; |
| PubChem CID | 9952928 |
| Appearance | Off-white to yellow solid powder |
| Density | 1.2±0.1 g/cm3 |
| Boiling Point | 651.2±55.0 °C at 760 mmHg |
| Flash Point | 347.7±31.5 °C |
| Vapour Pressure | 0.0±1.9 mmHg at 25°C |
| Index of Refraction | 1.634 |
| LogP | 4.54 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 6 |
| Heavy Atom Count | 29 |
| Complexity | 508 |
| Defined Atom Stereocenter Count | 0 |
| InChi Key | FHHNSSGZEIVGMS-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C24H20ClN3O/c25-22-12-10-19(11-13-22)18-6-8-21(9-7-18)24(29)27-16-23(28-15-14-26-17-28)20-4-2-1-3-5-20/h1-15,17,23H,16H2,(H,27,29) |
| Chemical Name | N-(2-(1H-imidazol-1-yl)-2-phenylethyl)-4'-chloro-[1,1'-biphenyl]-4-carboxamide |
| Synonyms | NVP-VID-400 NVP-VID 400 NVP-VID400 SDZ285428 SDZ 285428 SDZ-285428 SDZ285-428 SDZ 285-428 SDZ-285-428. |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vivo | Treatment for human trypanosomiasis may be possible by the selective suppression of protozoal CYP51 [1]. |
| References |
[1]. CYP51: A major drug target in the cytochrome P450 superfamily. Lipids. 2008 Dec;43(12):1117-25. |
Solubility Data
| Solubility (In Vitro) | DMSO : ~50 mg/mL (~124.41 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (5.18 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.4882 mL | 12.4412 mL | 24.8824 mL | |
| 5 mM | 0.4976 mL | 2.4882 mL | 4.9765 mL | |
| 10 mM | 0.2488 mL | 1.2441 mL | 2.4882 mL |